Cooperative Agreement NU58DP005404

This Project Grant award for $166,984 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports efforts to increase enrollment of adolescent and young adult (AYA) cancer patients on clinical trials at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins University. The project will develop and implement an "AYA: ALERT, Young Adult Navigation, Alliance" system to identify eligible AYA patients, provide them with timely information about...

This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $161,432 to The University of Texas MD Anderson Cancer Center to develop and evaluate a virtual, group-based expressive writing intervention for adolescent and young adult cancer survivors (AYACSS). The overarching goal is to enhance the quality of life and reduce stress among this population, who face multiple psychosocial disparities. The award will fund a 2-year research plan with the...

The National Cancer Institute (NCI) awarded a $664,259 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Duke University. The grant is for the development and evaluation of the "AYA STEPS" digital health intervention, which aims to help adolescent and young adult (AYA) cancer survivors manage their symptoms and improve engagement with post-treatment care. The project involves a randomized controlled trial to assess the efficacy of the AYA STEPS...

This $290,052 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and evaluation of a mobile-optimized intervention called PERCS-YA (Personalized Cancer Support for Young Adults) to reduce worry and distress among young adult cancer survivors. The award will fund stakeholder-engaged refinement of the PERCS-YA intervention, followed by a Phase II efficacy trial utilizing both a...

This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $361,807 to the University of Chicago to tailor and pilot test a technology-assisted cognitive behavioral therapy (TCBT) program for adolescents and young adults (AYAs) with hematological malignancies. The key objectives are to: 1) Collaborate with an advisory panel of AYA cancer survivors and stakeholders to refine the existing TCBT program "MYTH" for the specific needs of...

This Project Grant award for $517,732.00 was provided by the National Cancer Institute (NCI) under the Cancer Treatment Research Federal Grant Program (CFDA 93.395). The grant supports research at the University of Colorado-Denver to investigate how endocrine therapies and radiation therapy can be used in combination to decrease the risk of brain metastases in younger women with aggressive forms of breast cancer. The key objectives are to: 1) determine how endocrine therapies and radiation...

This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $156,000.00 to The Medical College of Wisconsin, Inc. to conduct a national cohort study examining breast cancer diagnostics, treatments, and outcomes in individuals on hormone therapy. The key objectives are to: 1) Create a national cohort of patients on hormone therapy with breast cancer from 23 institutions to collect detailed patient demographic, treatment, and outcome...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under CFDA 93.376 "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" to the Young Survival Coalition, Inc. The 5-year award period runs from September 30, 2024 to September 29, 2029. The grant supports the development and delivery of comprehensive psychosocial and structural support services for young breast cancer survivors and metastatic...

This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $273,211 to Connecticut Children's Medical Center to develop, refine, and assess a novel web-based intervention called the Reproductive and Sexual Health Patient Education and Communication Tool (RESPECT). The goal of RESPECT is to improve sexual and reproductive health communication between adolescent and young adult (AYA) oncology patients and their clinicians. The 5-year...

This Project Grant award from the National Cancer Institute (CFDA Program 93.393 - Cancer Cause and Prevention Research) to Virginia Commonwealth University is providing $577,778 to investigate the feasibility and acceptability of the FEARLESS protocol, a novel mindfulness-based intervention targeting fear of cancer recurrence (FCR) in patients with primary malignant brain tumors and their caregivers. The study aims to address key information gaps related to recruitment methodology, study...